Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline in Japanese CAP
NCT00575094Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2007
- Primary completion
- Mar 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tigecycline in community acquired pneumonia (CAP), sponsored by Pfizer. Primary endpoint: Clinical Response at Test-of-Cure (TOC) Visit. Started Nov 2007; status: completed.
02
Drugs
tigecycline
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00575094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00575094.